An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...

OraSure’s board is said to have rejected the proposal without entering discussions. This is Zwanziger’s second attempt to ...

EPHA4 pathway dysfunction causes axon pathfinding defects, resulting in impaired coordinated left-right locomotion by disrupting neural patterning and the function of central pattern generators, ...